DK1133571T3 - Fremgangsmåder og sammensætning til smertebehandling - Google Patents

Fremgangsmåder og sammensætning til smertebehandling

Info

Publication number
DK1133571T3
DK1133571T3 DK99963940T DK99963940T DK1133571T3 DK 1133571 T3 DK1133571 T3 DK 1133571T3 DK 99963940 T DK99963940 T DK 99963940T DK 99963940 T DK99963940 T DK 99963940T DK 1133571 T3 DK1133571 T3 DK 1133571T3
Authority
DK
Denmark
Prior art keywords
pain
patient
methods
composition
dose
Prior art date
Application number
DK99963940T
Other languages
English (en)
Inventor
Bruce M Cameron Sr
Robert C Allen
Original Assignee
Proteome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteome Sciences Inc filed Critical Proteome Sciences Inc
Application granted granted Critical
Publication of DK1133571T3 publication Critical patent/DK1133571T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/521—Single-layer analytical elements
    • G01N33/523—Single-layer analytical elements the element being adapted for a specific analyte
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • C12Q1/46—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase involving cholinesterase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01007—Acetylcholinesterase (3.1.1.7)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406—Neurotransmitters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406—Neurotransmitters
    • G01N33/944—Acetylcholine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2334/00—O-linked chromogens for determinations of hydrolase enzymes, e.g. glycosidases, phosphatases, esterases
    • C12Q2334/30—Naphthol derivatives, e.g. alpha-naphthyl-esters, i.e. alpha-NE, beta-naphthyl-esters, i.e. beta-NE
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2334/00—O-linked chromogens for determinations of hydrolase enzymes, e.g. glycosidases, phosphatases, esterases
    • C12Q2334/70—O-linked chromogens for determinations of hydrolase enzymes, e.g. glycosidases, phosphatases, esterases the product, e.g. phenol, naphthol being diazotised in situ, e.g. with Fast Red
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK99963940T 1998-11-23 1999-11-22 Fremgangsmåder og sammensætning til smertebehandling DK1133571T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10950498P 1998-11-23 1998-11-23
US14125599P 1999-06-30 1999-06-30

Publications (1)

Publication Number Publication Date
DK1133571T3 true DK1133571T3 (da) 2006-10-23

Family

ID=26807037

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99963940T DK1133571T3 (da) 1998-11-23 1999-11-22 Fremgangsmåder og sammensætning til smertebehandling

Country Status (10)

Country Link
US (1) US6764831B2 (da)
EP (1) EP1133571B1 (da)
AT (1) ATE331809T1 (da)
AU (1) AU2027600A (da)
CA (1) CA2351877C (da)
DE (1) DE69932180T2 (da)
DK (1) DK1133571T3 (da)
ES (1) ES2264278T3 (da)
MX (1) MXPA01005154A (da)
WO (1) WO2000031290A1 (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6659968B1 (en) * 2000-06-01 2003-12-09 Advanced Bionics Corporation Activity monitor for pain management efficacy measurement
US6690397B1 (en) * 2000-06-05 2004-02-10 Advanced Neuromodulation Systems, Inc. System for regional data association and presentation and method for the same
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
US7131004B1 (en) * 2001-08-31 2006-10-31 Silicon Image, Inc. Method and apparatus for encrypting data transmitted over a serial link
EP1517912A4 (en) * 2001-11-06 2006-07-05 Millennium Pharm Inc METHODS AND COMPOSITIONS FOR TREATING PAIN AND PAIN DISEASES USING GENES 577, 20739 OR 57145
EP1527781B1 (en) 2002-08-09 2008-07-23 Taisho Pharmaceutical Co., Ltd Antipruritic agent
US7155279B2 (en) * 2003-03-28 2006-12-26 Advanced Bionics Corporation Treatment of movement disorders with drug therapy
GB0320728D0 (en) * 2003-09-04 2003-10-08 Kilminster Shaun Test
US20060129069A1 (en) * 2004-12-14 2006-06-15 Apkarian A V Apparatus and method for pain measurement
US10042980B2 (en) 2005-11-17 2018-08-07 Gearbox Llc Providing assistance related to health
US8532938B2 (en) 2005-11-17 2013-09-10 The Invention Science Fund I, Llc Testing-dependent administration of a nutraceutical
US20070112592A1 (en) * 2005-11-17 2007-05-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Payments in providing assistance related to health
US8468029B2 (en) * 2005-11-17 2013-06-18 The Invention Science Fund I, Llc Subscriptions for assistance related to health
US7927787B2 (en) 2006-06-28 2011-04-19 The Invention Science Fund I, Llc Methods and systems for analysis of nutraceutical associated components
US7827042B2 (en) 2005-11-30 2010-11-02 The Invention Science Fund I, Inc Methods and systems related to transmission of nutraceutical associated information
US20080210748A1 (en) 2005-11-30 2008-09-04 Searete Llc, A Limited Liability Corporation Of The State Of Delaware, Systems and methods for receiving pathogen related information and responding
US7974856B2 (en) * 2005-11-30 2011-07-05 The Invention Science Fund I, Llc Computational systems and methods related to nutraceuticals
US20090253585A1 (en) * 2005-11-30 2009-10-08 Luda Diatchenko Identification of Genetic Polymorphic Variants Associated With Somatosensory Disorders and Methods of Using the Same
US10296720B2 (en) 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US8340944B2 (en) 2005-11-30 2012-12-25 The Invention Science Fund I, Llc Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US20070299693A1 (en) * 2006-06-23 2007-12-27 Searete Llc, A Limited Liability Corporation Customized visual marking for medication labeling
US8297028B2 (en) * 2006-06-14 2012-10-30 The Invention Science Fund I, Llc Individualized pharmaceutical selection and packaging
US8000981B2 (en) * 2005-11-30 2011-08-16 The Invention Science Fund I, Llc Methods and systems related to receiving nutraceutical associated information
US20080082272A1 (en) * 2005-11-30 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems and methods related to nutraceuticals
US20070287991A1 (en) * 2006-06-08 2007-12-13 Mckay William F Devices and methods for detection of markers of axial pain with or without radiculopathy
US8333697B2 (en) 2006-06-08 2012-12-18 Warsaw Orthopedic, Inc. Diagnostic kits and methods for diagnosis of axial pain with or without radiculopathy
US9757476B2 (en) * 2006-06-08 2017-09-12 Warsaw Orthopedic, Inc. Compositions and methods for diagnosis of axial pain with or without radiculopathy
US20070299695A1 (en) * 2006-06-23 2007-12-27 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Customized visual marking for medication labeling
US20080086339A1 (en) * 2006-06-23 2008-04-10 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Customized visual marking for medication labeling
US20080086338A1 (en) * 2006-06-23 2008-04-10 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Customized visual marking for medication labeling
CN101190330A (zh) * 2006-11-30 2008-06-04 深圳市鼎兴生物医药技术开发有限公司 胆碱酯酶在拮抗速激肽药物中的应用
US20090263370A1 (en) * 2006-11-30 2009-10-22 Guoliang Tao Methods for treating tachykinin-mediated diseases with cholinesterase
WO2014165732A1 (en) * 2013-04-04 2014-10-09 The Regents Of The University Of California System and method for utilizing exhaled breath for monitoring inflammatory states
US11751783B2 (en) * 2021-06-04 2023-09-12 Mirza Faizan System and method for mental state determination

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1598739C3 (de) 1965-01-26 1973-10-11 Merck Patent Gmbh, 6100 Darmstadt Mittel zur Bestimmung der Chohnesteraseaktivitat im Serum
US3433712A (en) 1965-01-28 1969-03-18 Horace W Gerarde Cholinesterase test
US3378463A (en) 1965-06-22 1968-04-16 Army Usa Method of measuring enzyme activity
US3410756A (en) 1966-05-27 1968-11-12 Army Usa Naphthyl esters as fluorogenic substrates for enzymes
US3438866A (en) 1967-03-21 1969-04-15 Pfizer & Co C Serum cholinesterase test
US3928594A (en) * 1974-06-24 1975-12-23 Albert W Cook Method of alleviating symptoms of multiple scleroisis
DE2914721A1 (de) 1978-04-17 1979-10-18 Kyowa Hakko Kogyo Kk Verfahren zur bestimmung der cholinesterase-aktivitaet sowie fuer dieses verfahren verwendbare cholin-derivate
JPS5935599B2 (ja) 1980-12-25 1984-08-29 株式会社 シノテスト研究所 コリンエステラ−ゼ活性測定法
JPS603839B2 (ja) 1981-04-08 1985-01-30 富士レビオ株式会社 コリンエステラ−ゼの活性測定法
JPS58155099A (ja) 1982-03-12 1983-09-14 Unitika Ltd コリンエステラ−ゼ定量用試薬
US4499185A (en) 1982-05-17 1985-02-12 Miles Laboratories, Inc. Test for esterase activity in a liquid sample
JPS60238000A (ja) 1984-05-10 1985-11-26 Nitto Boseki Co Ltd 新規なコリンエステラ−ゼ活性測定法
JPH0650997B2 (ja) 1986-04-15 1994-07-06 日東紡績株式会社 コリンエステラ−ゼ活性の新規測定方法
US4889797A (en) 1986-05-28 1989-12-26 Fuji Photo Film Co., Ltd. Dry analytical element having a spread control area for assaying enzyme activity
JPH0662521B2 (ja) 1988-02-24 1994-08-17 日東紡績株式会社 新規コリン誘導体及びそれを用いた血清コリンエステラーゼ活性測定法
US5604105B1 (en) 1990-10-12 1999-08-24 Spectral Diagnostics Inc Method and device for diagnosingand distinguishing chest pain in early onset thereof
AU667462B2 (en) 1990-11-30 1996-03-28 Monoclonetics International Incorporated Methods for the diagnosis of chronic lower back and cervical pain
US5272061A (en) 1991-09-20 1993-12-21 Eastman Kodak Company Assay for serum cholinesterase activity

Also Published As

Publication number Publication date
DE69932180T2 (de) 2007-06-14
US6764831B2 (en) 2004-07-20
WO2000031290A1 (en) 2000-06-02
CA2351877A1 (en) 2000-06-02
CA2351877C (en) 2012-01-24
EP1133571B1 (en) 2006-06-28
DE69932180D1 (de) 2006-08-10
AU2027600A (en) 2000-06-13
ATE331809T1 (de) 2006-07-15
ES2264278T3 (es) 2006-12-16
WO2000031290A9 (en) 2001-03-29
EP1133571A1 (en) 2001-09-19
US20020086343A1 (en) 2002-07-04
MXPA01005154A (es) 2003-06-06

Similar Documents

Publication Publication Date Title
DK1133571T3 (da) Fremgangsmåder og sammensætning til smertebehandling
Perinetti et al. Gingival crevicular fluid alkaline phosphatase activity as a non‐invasive biomarker of skeletal maturation
Ursell Relationships between alveolar bone levels measured at surgery, estimated by transgingival probing and clinical attachment level measurements
Rodd et al. Pulpal expression of TRPV1 in molar incisor hypomineralisation
DE60329165D1 (de) Detektion und/oder beobachtung von synuclein-assoziierten krankheiten
ATE440536T1 (de) Verfahren zur diagnose, behandlung und prävention von knochenverlust
Lamster et al. The relationship of β‐glucuronidase activity in crevicular fluid to probing attachment loss in patients with adult periodontitis: Findings from a multicenter study
Lepinski et al. Bradykinin levels in dental pulp by microdialysis
Seppäläinen Peripheral neuropathy in forest workers. A field study
Ozdogan et al. Salivary opiorphin in dental pain: A potential biomarker for dental disease
DE602004026767D1 (de) Immunsorbens-bluttests zur beurteilung von paroxysmalen zerebralentladungen
Svensson et al. Induction and assessment of experimental muscle pain
Bendtsen et al. Amitriptyline, a combined serotonin and noradrenaline re-uptake inhibitor, reduces exteroceptive suppression of temporal muscle activity in patients with chronic tension-type headache
Hartmann et al. Neurophysiological changes associated with implant placement
Kutlu et al. Peripheral neuropathy and visual evoked potential changes in workers exposed to n-hexane
Kim et al. Prediction of early caries prognosis after fluoride application based on the severity of lesions: An in situ study
Cruccu et al. Diagnosis of trigeminal neuralgia: a new appraisal based on clinical and neurophysiological findings
Eick et al. Persistence of Porphyromonas gingivalis is a negative predictor in patients with moderate to severe periodontitis after nonsurgical periodontal therapy
Bruyn et al. Clinically silent dysfunction of dorsal columns and dorsal spinocerebellar tracts in hereditary spastic paraparesis
Caligiuri et al. Asymmetry of neuroleptic-induced rigidity: development of quantitative methods and clinical correlates
Trevett et al. Electrophysiological findings in patients envenomed following the bite of a Papuan taipan (Oxyuranus scutellatus canni)
Ramadoss et al. Salivary stimulatory effect of novel low level transcutaneous electro neurostimulator in geriatric patients with xerostomia
RU2351280C1 (ru) Способ дифференциальной диагностики заболеваний височно-нижнечелюстного сустава
Lee et al. Influence of topical capsaicin on facial sensitivity in response to experimental pain
Konasiewicz et al. Somatosensory evoked potentials and intracranial pressure in severe head injury